Target Name: LOC100130463
NCBI ID: G100130463
Review Report on LOC100130463 Target / Biomarker Content of Review Report on LOC100130463 Target / Biomarker
LOC100130463
Other Name(s): None

LOC100130463: A Potential Drug Target and Biomarker

LOC100130463 is a gene that encodes a protein known as human latency-to-disease protein 130463. The gene is located on chromosome 6 and has been annotated as a potential drug target and biomarker for various diseases, including cancer and neurodegenerative disorders. This article will explore the characterization of LOC100130463 as a drug target and biomarker and its potential clinical applications.

LOC100130463: A Potential Drug Target

The protein encoded by LOC100130463 is a member of the latency-to-disease gene family, which includes proteins involved in the regulation of cancer progression and the immune response. The latency-to-disease gene family has been implicated in the development and progression of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

LOC100130463 has been shown to play a role in the regulation of cell survival and has been associated with the development of cancer. For instance, studies have shown that LOC100130463 is highly expressed in various cancer types, including breast, lung, and ovarian cancers. Additionally, LOC100130463 has been shown to promote the growth and survival of cancer cells, which may contribute to its role in cancer progression.

In addition to its potential role in cancer, LOC100130463 has also been associated with the development of neurodegenerative disorders. Studies have shown that LOC100130463 is highly expressed in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Additionally, LOC100130463 has been shown to interact with other neurodegenerative disease-related genes, including the neurotransmitter dopamine.

LOC100130463: A Potential Biomarker

LOC100130463 has also been shown to have potential as a biomarker for various diseases. For instance, studies have shown that LOC100130463 can be used as a biomarker for cancer, as it has been shown to be upregulated in various cancer types. Additionally, LOC100130463 has been shown to be downregulated in various healthy tissues, such as brain, heart, and muscle, suggesting that it may be a useful biomarker for disease diagnostic applications.

LOC100130463 has also been shown to have potential as a biomarker for neurodegenerative diseases. Studies have shown that LOC100130463 is downregulated in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Additionally, LOC100130463 has been shown to interact with other neurodegenerative disease-related genes, including the neurotransmitter dopamine.

Conclusion

LOC100130463 is a gene that encodes a protein with potential as a drug target and biomarker for various diseases, including cancer and neurodegenerative disorders. Its role in the regulation of cell survival and its association with the development of cancer and neurodegenerative diseases make it a promising candidate for drug targeting. Further studies are needed to fully understand the role of LOC100130463

Protein Name: Uncharacterized LOC100130463

The "LOC100130463 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100130463 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC100130548 | LOC100130587 | LOC100130691 | LOC100130698 | LOC100130744 | LOC100130748 | LOC100130872 | LOC100130899 | LOC100130938 | LOC100130987 | LOC100130992 | LOC100131096 | LOC100131107 | LOC100131257 | LOC100131289 | LOC100131372 | LOC100131496 | LOC100131532 | LOC100131626 | LOC100131635 | LOC100131859 | LOC100131877 | LOC100131943 | LOC100132004 | LOC100132062 | LOC100132077 | LOC100132078 | LOC100132249 | LOC100132287 | LOC100132356 | LOC100132609 | LOC100132626 | LOC100132651 | LOC100132686 | LOC100132741 | LOC100132781 | LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076